Dr. Reddy’s forays into child nutrition space with the launch of CeleHealth Kidz Gummies in India
• The immunity supporting gummies are backed by scientifically formulated combination of ingredients such as Wellmune®, prebiotics and other essential Vitamins and Minerals
• Wellmune® is a clinically proven ingredient to help reduce number of sick days in children by enhancing their innate immunity
• The gummies come in exciting flavours and playful shape
• The launch enables Dr. Reddy’s to help address the issue of recurrent respiratory infections among children in India
• Dr. Reddy’s entry into child nutrition widens its position in the nutraceutical segment which also includes the award-winning nutrition product ‘Celevida’ for dietary management of diabetes
India; July 06, 2023 – Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, today announced the launch of CeleHealth Kidz Immuno Plus Gummies in India . The immunity supporting gummies are fortified by scientifically formulated combination of ingredients such as Wellmune® , prebiotics and other essential vitamins and minerals.
Wellmune® is a form of clinically studied beta-glucan and a proven ingredient to help reduce sick days in children by enhancing their innate immunity . The gummies launch marks Dr. Reddy’s’ entry into the child nutrition space strengthening its position in the nutraceutical segment. Its nutrition portfolio includes products in adult nutrition, child nutrition, hospital & clinical nutrition and general health & wellness. Dr. Reddy’s flagship nutraceutical offering is the nutrition product Celevida for dietary management of diabetes.
Dr. Reddy’s CeleHealth Kidz Immuno Plus gummies aim to address the nutritional requirements due to the growing issues around child immunity in India. Research indicates that more than 93.7% of children suffer from recurrent cough and cold . Such recurrent infections appear throughout the year in children especially during seasonal changes. Weakened immunity has a direct correlation with nutrition deficiencies due to picky eating habits in children .
In view of the existing clinical data and research, the nutrition team of Dr. Reddy’s studied consumer need and developed a unique formulation with high science to help improve the innate immunity or the first line of defence in a child’s body via scientifically designed gummies with Wellmune®. The product contains prebiotics to help support gut health and is a plant-based source of Vitamin D3. Alongside, it also has other essential vitamins and minerals , making it a scientifically-backed choice in immunity nutrition supplements for kids.
Speaking about the launch, M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), said: “In the field of medical nutrition, the starting point for us is understanding the disease area and the unmet need of patients and consumers. This helps us create a differentiated product, i.e., one that is science-based and clinically proven.
The consumer insights and marketing team reached out to multiple consumers to understand the need-gap in order to design the right product that they need. We also ensured that the product is palatable for patients and consumers and attractively shaped to appeal to children. Our dedicated nutraceuticals R&D laboratory has helped us design our product accordingly. As our nutraceutical portfolio expands, we see it as an important medium to long-term growth area.”
CeleHealth Kidz gummies come in two flavours – Pulpy Mango and Pink Guava. The product is available across the country in leading chemists, e-Commerce and e-Pharmacies. Currently, a pack of 30 gummies is priced at Rs. 480.
Patients and consumers can consult their doctors or pediatricians for more information.
About Dr. Reddy’s nutraceutical portfolio: Formed in 2019, Team Nutraceuticals at Dr. Reddy’s has been building a strong portfolio of specially designed products for dietary management of nutritional requirements in the metabolic & gastro-intestinal disorders, hospital & clinical nutrition and general wellness and immunity segments with both prescription and OTC products.
Reaching customers through retail, hospital and e-commerce routes, our portfolio includes well-recognised brands such as Celevida, Celevida Liv, Celevida Maxx, Celevida DLS, Celevida EN and CeleHealth . Our nutrition portfolio aims to provide clinically proven differentiated and innovative solutions in chosen therapy areas. In 2021, we inaugurated a dedicated nutraceuticals R&D centre in Bachupally, Hyderabad. We see nutraceuticals as an important medium to long-term growth area.
